Cargando…

Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study

Detalles Bibliográficos
Autores principales: Bjekić-Macut, Jelica, Živković, Teodora Beljić, Kocić, Radivoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104262/
https://www.ncbi.nlm.nih.gov/pubmed/29569224
http://dx.doi.org/10.1007/s13300-018-0406-4
_version_ 1783349453859586048
author Bjekić-Macut, Jelica
Živković, Teodora Beljić
Kocić, Radivoj
author_facet Bjekić-Macut, Jelica
Živković, Teodora Beljić
Kocić, Radivoj
author_sort Bjekić-Macut, Jelica
collection PubMed
description
format Online
Article
Text
id pubmed-6104262
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-61042622018-08-27 Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study Bjekić-Macut, Jelica Živković, Teodora Beljić Kocić, Radivoj Diabetes Ther Author Correction Springer Healthcare 2018-03-22 2018-04 /pmc/articles/PMC6104262/ /pubmed/29569224 http://dx.doi.org/10.1007/s13300-018-0406-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Author Correction
Bjekić-Macut, Jelica
Živković, Teodora Beljić
Kocić, Radivoj
Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
title Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
title_full Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
title_fullStr Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
title_full_unstemmed Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
title_short Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
title_sort author correction: clinical benefit of basal insulin analogue treatment in persons with type 2 diabetes inadequately controlled on prior insulin therapy: a prospective, noninterventional, multicenter study
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104262/
https://www.ncbi.nlm.nih.gov/pubmed/29569224
http://dx.doi.org/10.1007/s13300-018-0406-4
work_keys_str_mv AT bjekicmacutjelica authorcorrectionclinicalbenefitofbasalinsulinanaloguetreatmentinpersonswithtype2diabetesinadequatelycontrolledonpriorinsulintherapyaprospectivenoninterventionalmulticenterstudy
AT zivkovicteodorabeljic authorcorrectionclinicalbenefitofbasalinsulinanaloguetreatmentinpersonswithtype2diabetesinadequatelycontrolledonpriorinsulintherapyaprospectivenoninterventionalmulticenterstudy
AT kocicradivoj authorcorrectionclinicalbenefitofbasalinsulinanaloguetreatmentinpersonswithtype2diabetesinadequatelycontrolledonpriorinsulintherapyaprospectivenoninterventionalmulticenterstudy